BNP Paribas Financial Markets’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461K | Buy |
271,195
+35,794
| +15% | +$60.9K | ﹤0.01% | 2605 |
|
|
2025
Q1 | $372K | Buy |
235,401
+70,806
| +43% | +$112K | ﹤0.01% | 2534 |
|
|
2024
Q4 | $295K | Buy |
164,595
+120,100
| +270% | +$215K | ﹤0.01% | 2829 |
|
|
2024
Q3 | $270K | Buy |
44,495
+900
| +2% | +$5.45K | ﹤0.01% | 2419 |
|
|
2024
Q2 | $229K | Buy |
43,595
+1,100
| +3% | +$5.79K | ﹤0.01% | 2390 |
|
|
2024
Q1 | $361K | Sell |
42,495
-14,971
| -26% | -$127K | ﹤0.01% | 2368 |
|
|
2023
Q4 | $379K | Buy |
57,466
+35,771
| +165% | +$236K | ﹤0.01% | 2260 |
|
|
2023
Q3 | $67K | Buy |
21,695
+7,290
| +51% | +$22.5K | ﹤0.01% | 2735 |
|
|
2023
Q2 | $38.9K | Buy |
14,405
+4,976
| +53% | +$13.4K | ﹤0.01% | 2905 |
|
|
2023
Q1 | $28K | Buy |
9,429
+7,929
| +529% | +$23.5K | ﹤0.01% | 2862 |
|
|
2022
Q4 | $3.78K | Buy |
+1,500
| New | +$3.78K | ﹤0.01% | 3025 |
|
|
2022
Q2 | – | Sell |
-792
| Closed | -$4.9K | – | 3477 |
|
|
2022
Q1 | $4.9K | Buy |
792
+736
| +1,314% | +$4.55K | ﹤0.01% | 3282 |
|
|
2021
Q4 | $795 | Sell |
56
-397
| -88% | -$5.64K | ﹤0.01% | 3420 |
|
|
2021
Q3 | $3.62K | Buy |
453
+22
| +5% | +$176 | ﹤0.01% | 3134 |
|
|
2021
Q2 | $12.3K | Buy |
+431
| New | +$12.3K | ﹤0.01% | 3071 |
|